Answers are grounded in this paper and cite their sources.
Metabolic dysfunction-associated steatotic liver disease (MASLD) is the most common chronic liver condition worldwide, yet the mechanisms that drive progression from simple steatosis to steatohepatitis and fibrosis remain incompletely defined. Ferroptosis, an iron-dependent form of regulated cell death caused by uncontrolled peroxidation of polyunsaturated phospholipids, has emerged as a plausible mechanism linking metabolic overload, iron dysregulation, and oxidative injury in the liver. Diet influences three principal determinants of ferroptotic susceptibility: the fatty acid composition of membrane phospholipids, the size and accessibility of the labile iron pool, and the supply of selenium required to synthesise the selenoenzyme glutathione peroxidase 4 (GPX4). This critical narrative review synthesises mechanistic, preclinical, and clinical evidence on these three nutritional axes and their interactions in MASLD, and appraises the translational implications. Literature was identified through structured searches of PubMed/MEDLINE, Scopus, and Web of Science, and the review was guided by the SANRA quality criteria. The evidence indicates that (i) monounsaturated fatty acids promote a ferroptosis-resistant membrane state, whereas the vulnerability of polyunsaturated phospholipids depends on the surrounding antioxidant and iron context; (ii) hepatic iron deposition pattern and serum ferritin are associated with histological severity in MASLD, although causality is unproven; and (iii) selenium sufficiency is required for GPX4 function, but the relationship between selenium status and MASLD outcomes is non-linear and not supported by adequate trials. Most mechanistic evidence arises from cell and rodent models, and no human trial has tested whether nutritional modulation of ferroptosis changes MASLD outcomes. We propose an integrative triple-axis framework in which fatty acid quality (substrate), iron status (catalyst), and selenium-dependent defences (repair) jointly determine ferroptotic susceptibility. Until direct evidence is available, guideline-concordant, Mediterranean-style, minimally processed dietary patterns with energy balance remain the pragmatic approach, and indiscriminate iron or selenium supplementation should be avoided. Priority research needs include validated human ferroptosis biomarkers, selenium-status-stratified trials, and factorial studies of nutrient interactions
No takes yet. Share an insight, caveat, or question.
Teja et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: